Strengthened collaboration between the UK’s MHRA and US FDA to drive innovation and accelerate patient access to latest technologies 

MHRA National AI Commission launched with UK and US experts to shape safe, transparent use of AI in healthcare 

New international reliance routes to improve international investment and UK access to medical devices already approved by trusted regulators, including the US FDA 

The  UK’s Medicines and Healthcare products Regulatory Agency (MHRA) will  today outline moves to deepen collaboration with the US on medical technology regulation, with initiatives to accelerate innovation, strengthen patient safety, and reduce transatlantic barriers to market access. 

Speaking at the Advanced Medical Technology Association (AdvaMed) conference in San Diego, MHRA C

See Full Page